The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?

被引：8
|
作者：
Trainor, S. [1 ]
Choudhury, A. [2 ,3 ]
Huddart, R. [4 ,5 ]
Kiltie, A. E. [6 ]
Kockelbergh, R. [7 ]
Turner, W. [8 ]
Birtle, A. [9 ]
Crabb, S. J. [10 ]
机构：
[1] St Jamess Inst Oncol, Dept Med Oncol, Leeds, W Yorkshire, England
[2] Univ Manchester, Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[3] Univ Manchester, Manchester Canc Res Ctr, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[4] Inst Canc Res, Sutton, Surrey, England
[5] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[6] Univ Oxford, CRUK, MRC, Oxford Inst Radiat Oncol, Oxford, England
[7] Univ Hosp Leicester, Dept Urol, Leicester, Leics, England
[8] Cambridge Univ Hosp NHS Fdn Trust, Dept Urol, Cambridge, England
[9] Royal Preston Hosp, Rosemere Canc Ctr, Preston, Lancs, England
[10] Univ Southampton, Canc Sci Unit, Southampton, Hants, England
来源：
CLINICAL ONCOLOGY | 2017年 / 29卷 / 06期
关键词：
PERIOPERATIVE CHEMOTHERAPY; PATIENT EXPERIENCE; CARCINOMA; VINFLUNINE; CYSTECTOMY; PLUS;
D O I：
10.1016/j.clon.2017.01.040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：344 / 347
页数：4
相关论文
共 50 条
  • [1] National Institute for Health and Care Excellence (NICE) guidance on heart valve disease
    Shah, Benoy Nalin
    HEART, 2023, 109 (11) : 817 - 822
  • [2] A New Dawn for Bladder Cancer? Recommendations from the National Institute for Health and Care Excellence (NICE) on Managing Bladder Cancer
    Huddart, R. A.
    Jones, R.
    Choudhury, A.
    CLINICAL ONCOLOGY, 2015, 27 (07) : 380 - 381
  • [3] About the National Institute for Health and Care Excellence - NICE
    Chalkidou, Kalipso
    ACTA MEDICA PORTUGUESA, 2013, 26 (05): : 483 - 484
  • [4] CURRENT TREND OF UTILITY VALUES IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) TECHNOLOGY APPRAISAL GUIDANCE
    Azuma, M.
    Nojima, T.
    Matsushita, Y.
    VALUE IN HEALTH, 2019, 22 : S724 - S724
  • [5] Preoperative screening for sickle cell disease and guidance from the National Institute for Health and Care Excellence (NICE)
    O'Connor, A.
    Power, A.
    Kanatas, A.
    Russell, J.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2017, 55 (09): : 984 - +
  • [6] Ovarian cancer: Review of the National Institute for Clinical Excellence (NICE) guidance recommendations
    Johnston, SRD
    CANCER INVESTIGATION, 2004, 22 (05) : 730 - 742
  • [7] The true value of The National Institute for Health and Care Excellence guidance
    Adamson, Philip D.
    Newby, David E.
    HEART, 2017, 103 (13) : 1056 - 1056
  • [8] AN ANALYSIS OF RESTRICTED RECOMMENDATIONS BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
    Rahman, M.
    Asaadi, A.
    VALUE IN HEALTH, 2019, 22 : S609 - S609
  • [9] THE INTERNATIONAL IMPACT OF NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) DECISIONS
    Brassel, S.
    Oliver, E.
    Henderson, N.
    O'Neill, P.
    Saeed, F. O.
    Gibbons, I
    Allen, R.
    Hudson, R.
    Malottki, K.
    Wentzel, H.
    Largeron, N.
    Garau, M.
    VALUE IN HEALTH, 2022, 25 (12) : S266 - S266
  • [10] A REVIEW OF THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) MEDICAL TECHNOLOGIES GUIDANCE OVER THE LAST 10 YEARS
    Green, M.
    Harper, S.
    Wright, D. L.
    VALUE IN HEALTH, 2020, 23 : S406 - S406
12345